Áttétes emlőrák: vizsgálatok itt: Norvégia
6 of 7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA First-in-Human Phase 1 Safety and Biodistribution of [177Lu]Lu-ABY-271 in Subjects With HER2-positive Metastatic Breast Cancer
- Where
- Oslo
- Életkor
- 18 év and over
- People
- 21 worldwide
- Run by
- Affibody
See details and how to joinNCT07081555 - 3. fázisTaking peopleStereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer
- Where
- Bergen, Oslo, Tromsø, Trondheim
- Életkor
- 18 év and over
- People
- 345 worldwide
- Run by
- Vastra Gotaland Region
See details and how to joinNCT05377047 - 1. fázisNot yet taking people in NorvégiaA First-in-Human phase 1, open-label, two-stage, randomized trial to assess the safety, tolerability, and biodistribution of [177Lu]Lu-ABY-271 in tumors and critical organs in subjects with HER2-positive metastatic breast cancer
- Where
- Oslo
- Életkor
- 18 év and over
- People
- 30 worldwide
- Run by
- Affibody AB
See details and how to join2024-518360-13-00 - 4. fázisTaking peopleIMPlementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older bReasT cAncer patieNTs – a pragmatic randomized-controlled trial (IMPORTANT trial)
- Where
- Lorenskog
- Életkor
- 65 év and over
- People
- 495 worldwide
- Run by
- Region Oerebro Laen
See details and how to join2023-506620-87-00 - 3. fázisNot yet taking people in NorvégiaImplementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
- Where
- Oslo
- Életkor
- 70 év and over
- People
- 495 worldwide
- Run by
- Region Örebro County
See details and how to joinNCT06044623 - 2. fázisTaking peopleNicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients
- Where
- Lørenskog
- Életkor
- 18 év and over
- People
- 60
- Run by
- University Hospital, Akershus
See details and how to joinNCT05732051